arXiv (All)
open access
De novo design of monoclonal and bispecific antibodies with OFAntibody
Recent advances in generative protein design have enabled de novo antibody generation with explicit target and epitope conditioning. However, most existing approaches remain formulated around a single antigen-antibody interface, whereas bispecific antibody design requires modeling multi-component co
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Bispecific antibodies for cancer therapy: evolution of structural formats and co-targeting strategies from wet-lab to AI-driven in silico modeling.#442911
- Multi-Objective Amortized CDRH3 Sequence Sampling Diversifies Promising Antibody Candidates#1341802
- Immune Monitoring in Metastatic Melanoma#905658
- The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined with Lenvatinib in NSCLC.#969600
- Automated synthetic cell-based screening for designed proteins with emergent functions.#461509
Record · ID 1233587
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive